These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18823649)

  • 21. Race and ethnicity and breast cancer outcomes in an underinsured population.
    Komenaka IK; Martinez ME; Pennington RE; Hsu CH; Clare SE; Thompson PA; Murphy C; Zork NM; Goulet RJ
    J Natl Cancer Inst; 2010 Aug; 102(15):1178-87. PubMed ID: 20574040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach.
    Kim S; Dolecek TA; Davis FG
    Soc Sci Med; 2010 Jul; 71(2):274-281. PubMed ID: 20483517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Black race independently predicts worse survival in uterine carcinosarcoma.
    Erickson BK; Doo DW; Zhang B; Huh WK; Leath CA
    Gynecol Oncol; 2014 May; 133(2):238-41. PubMed ID: 24613675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial disparities in young women with endometrial cancer.
    Mukerji B; Baptiste C; Chen L; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2018 Mar; 148(3):527-534. PubMed ID: 29307452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.
    Stewart SL; Harewood R; Matz M; Rim SH; Sabatino SA; Ward KC; Weir HK
    Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5138-5159. PubMed ID: 29205312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
    Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
    Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
    Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
    J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial Differences in Survival From Epithelial Ovarian Cancer Are Associated With Stage at Diagnosis and Use of Neoadjuvant Therapy: A 10-Year Single-Institution Experience With a Racially Diverse Urban Population.
    Miller EM; Tymon-Rosario J; Strickler HD; Xie X; Xue X; Kuo DYS; Makhija SK; Nevadunsky NS
    Int J Gynecol Cancer; 2018 May; 28(4):749-756. PubMed ID: 29538252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does race predict survival for women with invasive breast cancer?
    Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
    Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization.
    McGuire V; Herrinton L; Whittemore AS
    Epidemiology; 2002 Mar; 13(2):231-4. PubMed ID: 11880767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demographic, presentation, and treatment factors and racial disparities in ovarian cancer hospitalization outcomes.
    Akinyemiju TF; Naik G; Ogunsina K; Dibaba DT; Vin-Raviv N
    Cancer Causes Control; 2018 Mar; 29(3):333-342. PubMed ID: 29429013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disparities in ovarian cancer treatment and overall survival according to race: An update.
    Huffman DL; Jayakrishnan TT; Shankar K; Peterson CE; Wegner RE
    Gynecol Oncol; 2021 Sep; 162(3):674-678. PubMed ID: 34261593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial differences in colorectal cancer survival at a safety net hospital.
    Tapan U; Lee SY; Weinberg J; Kolachalama VB; Francis J; Charlot M; Hartshorn K; Chitalia V
    Cancer Epidemiol; 2017 Aug; 49():30-37. PubMed ID: 28538169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy?
    Maxwell GL; Tian C; Risinger JI; Hamilton CA; Barakat RR;
    Cancer; 2008 Sep; 113(6):1431-7. PubMed ID: 18698590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials.
    Farley JH; Tian C; Rose GS; Brown CL; Birrer M; Maxwell GL
    Cancer; 2009 Sep; 115(18):4210-7. PubMed ID: 19536873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of comorbid conditions on racial disparities in endometrial cancer survival.
    Ruterbusch JJ; Ali-Fehmi R; Olson SH; Sealy-Jefferson S; Rybicki BA; Hensley-Alford S; Elshaikh MA; Gaba AR; Schultz D; Munkarah AR; Cote ML
    Am J Obstet Gynecol; 2014 Dec; 211(6):627.e1-9. PubMed ID: 24954655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial disparity in colorectal cancer: the role of equal treatment.
    Laryea JA; Siegel E; Klimberg S
    Dis Colon Rectum; 2014 Mar; 57(3):295-302. PubMed ID: 24509450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer.
    Du XL; Sun CC; Milam MR; Bodurka DC; Fang S
    Int J Gynecol Cancer; 2008; 18(4):660-9. PubMed ID: 17892451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian cancer risk factors in African-American and white women.
    Moorman PG; Palmieri RT; Akushevich L; Berchuck A; Schildkraut JM
    Am J Epidemiol; 2009 Sep; 170(5):598-606. PubMed ID: 19605513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes.
    Lenze NR; Farquhar D; Sheth S; Zevallos JP; Blumberg J; Lumley C; Patel S; Hackman T; Weissler MC; Yarbrough WG; Zanation AM; Olshan AF
    Laryngoscope; 2021 Jun; 131(6):1301-1309. PubMed ID: 33170518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.